ACCEPTED MANUSCRIPT
1-Benzyl-3-(difluoromethyl)piperidin-3-ol 18 was prepared according to general procedure A. The
product was purified by column chromatography (Hexanes : EtOAc = 1:1+3% triethylamine, Rf=0.5).
Colorless liquid; 4.03 g (yield 54%). Alternatively, the product can be purified by distillation (2.7
mbar, 119–120 ºC); νmax(KBr) 3600-3200 (br), 2948, 2806, 1662, 1585, 1454, 1371, 1297, 1147, 1105,
1058 cm-1; 1H NMR (500 MHz, CDCl3), δ: 7.35-7.19 (m, 5H), 5.61 (t, J = 55.9 Hz, 1H), 3.55 (s, 2H),
3.31 (s, 1H), 2.76 (d, J = 10.7 Hz, 1H), 2.67 (d, J = 11.2 Hz, 1H), 2.22 (d, J = 11.0 Hz, 1H), 2.07 (td, J
= 11.3, 3.2 Hz, 1H), 1.89-1.74 (m, 1H), 1.73 – 1.55 (m, 2H), 1.50 (dt, J = 13.1, 6.6 Hz, 1H); 13C NMR
(101 MHz, CDCl3), δ: 137.52 (s), 129.0 (s), 128.4 (s), 127.4 (s), 116.7 (t, J = 245.6 Hz), 70.5 (t, J =
19
21.6 Hz), 62.7 (s), 57.4 (t, J = 3.9 Hz), 53.2 (s), 28.2 (s), 20.5 (s); F NMR (376 MHz, CDCl3), δ: -
134.90 (d, J = 56.0 Hz). Anal. calcd. for C13H17F2NO: C, 64.71; H, 7.10; N, 5.81. Found: C, 64.96; H,
7.29; N, 6.01.
1-Benzhydryl-3-(difluoromethyl)azetidin-3-ol 19 was prepared according to general procedure С.
The product was purified by column chromatography (Hexanes : EtOAc = 2:1, Rf=0.55). Yellow oil;
1.61 g (yield 18%); νmax(KBr) 3600-3200 (br), 3062, 3027, 2958, 2848, 1806, 1599, 1492, 1452, 1226,
1
1095, 1068, 1027 cm-1; H NMR (500 MHz, CDCl3), δ: 7.50 – 7.15 (m, 10H), 6.01 (t, J = 55.6 Hz,
1H), 4.45 (s, 1H), 3.47 (d, J = 9.4 Hz, 2H), 3.17 (s), 3.11 (d, J = 9.3 Hz, 2H). 13C NMR (126 MHz,
CDCl3), δ: 141.6 (s), 128.7 (s), 127.49 (s), 115.5 (t, J = 243.6 Hz), 77.5 (s), 69.5 (t, J = 23.1 Hz), 60.3
(t, J = 3.8 Hz). 19F NMR (376 MHz, CDCl3), δ: -134.17 (d, J = 55.7 Hz). HRMS (EI+ + 3NBA) calcd.
for [M+H]+ C17H18F2NO+ 290.1351, found 290.1350.
1-Benzylpyrrolidin-3-yl-1,1-difluoropropan-2-ol 20 was prepared according to general procedure
A. The product was purified by column chromatography (Hexanes : EtOAc = 1:1+3% triethylamine,
Rf=0.5). Colorless liquid; 3.71 g (yield 47%); νmax(KBr) 3600-3200 (br), 2973, 2807, 1658, 1454,
1380, 1352, 1211, 1128, 1089, 1061 cm-1; 1H NMR (500 MHz, CDCl3), δ: 7.43 – 7.20 (m, 1H), 5.65 (t,
J = 57 Hz, 0.6H), 5.59 (t, J = 56,35 Hz, 0.4H), 3.91 (s, 1H), 3.63 (s, 2H), 2.95 (d, J = 7.9 Hz, 0,44H),
2.90 – 2.73 (m, 1.7H), 2.50 (t, J = 8.1 Hz, 0.7H), 2.44 – 2.23 (m, 2.6H), 2.06 – 1.86 (m, 2.24H), 1.24
(s, 1.77H), 1.20 (s, 1.35H);13C NMR (126 MHz, CDCl3), δ: 138.5 (s), 138.3 (s), 128.7 (s), 128.7 (s),
128.6 (s), 128.5 (s), 128.4 (s), 127.4 (s), 127.3 (s), 117.9 (t, J = 249.28 Hz), 117.2 (t, J = 247.38 Hz),
74.0 (t, J = 20.39 Hz), 73.7 (s), 73.7 (s), 73.7 (t, J = 20.11 Hz), 60.0 (s), 59,8 (s), 55.4 (s), 55.0 (s),
19
53.3 (s), 52.7 (s), 41.9 (s), 41.1 (s), 24.6 (s), 24.1 (s), 19.1 (s), 18.4 (s); F NMR (376 MHz, CDCl3),
δ: -127.9 (dd, J = 280.2 Hz, 56.3 Hz, 1F), -134.1 (dd, J = 280.1, J = 56.6 Hz, 1F), -129.0 (dd, J =
283.8 Hz, 56.1 Hz, 1F), -136.6 (dd, J = 283.8, J = 57.2 Hz, 1F). HRMS (EI+ + 3NBA) calcd. for
[M+H]+ C14H20F2NO+ 256.1507, found 256.1507.
1,1-Difluoro-2-(pyridin-4-yl)propan-2-ol 21 was prepared according to general procedure C. The
product was purified by column chromatography (Hexanes : EtOAc = 1:2, Rf=0.3). White solid; 3.91 g
(yield 73%); m.p. 84–85 ºС; νmax(KBr) 3300-3000 (br), 2985, 2809, 2636, 1608, 1417, 1384, 1228,
1159, 1106, 1061, 1007 cm-1; 1H NMR (500 MHz, CDCl3), δ: 8.53 (d, J = 5.9 Hz, 2H), 7.49 (d, J = 5.6
11